EnsoData (AI, Analytics) — Funding, Investors & Signals 2026

EnsoData

Empowering clinicians with #waveformAI 🍍

Founded 2015

Madison, United States 57 employees Series A Total: $31.05M AI, Analytics +2

EnsoData is an AI and Machine Learning startup empowering clinicians with #waveformAI 🍍. Leveraging Artificial Intelligence (AI), the company aims to facilitate rapid, accurate, and affordable diagnoses for major health threats. Over the past eight years, EnsoData has been at the forefront of applying AI and ML to healthcare, particularly in sleep medicine, to address critical issues in diagnosis and treatment decision-making. The company's FDA-cleared solution, EnsoSleep, provides diagnostic analysis of in-lab sleep studies and was expanded in 2021 to include home sleep studies, a viewing and reporting platform, and total sleep time measurement. The recent FDA clearance for the EnsoSleep PPG algorithm in February 2024 further demonstrates EnsoData's commitment to innovation. This new algorithm harnesses wearable FDA-cleared pulse oximetry technology as a diagnostic tool, offering a more cost-effective and accessible solution for clinicians. The $20.00M Series A investment received in April 2022 from Colle Capital, M25, Zetta Venture Partners, HealthX Ventures, Supermoon Capital, Venture Investors, Justin Mortara, Inspire Medical Systems, and Frederick Robertson underscores the investor confidence in EnsoData's potential to enhance healthcare turnaround times, address patient backlogs, and improve overall patient care and health outcomes. Based in the United States, EnsoData continues to pave the way for advancements in AI and Analytics within the healthcare industry.

Funding Stage	Amount	Investors	Lead Investors	Date
Series A	••••••	9	•••• ••••	27 Apr 2022
Series A	••••••	10	•••• ••••	10 Jun 2020
Seed Round	••••••	5		02 Mar 2018
Non Equity Assistance	••••••	1		12 Sep 2017
Seed Round	••••••	1		13 Apr 2016

Funding Stage

Amount

Investors

Lead Investors

Date

Series A

••••••

•••• ••••

27 Apr 2022

Series A

••••••

•••• ••••

10 Jun 2020

Seed Round

••••••

02 Mar 2018

Non Equity Assistance

••••••

12 Sep 2017

Seed Round

••••••

13 Apr 2016

FAQ About EnsoData

Empowering clinicians with #waveformAI 🍍

EnsoData was founded in 2015.

EnsoData is headquartered in Madison, United States.

EnsoData operates in the following industries: AI, Analytics, Health Care, Machine Learning.

EnsoData has approximately 57 employees.

EnsoData has completed 6 funding rounds, raising a total of $31.05M. The latest funding stage is Series A.

Top alternatives and competitors to EnsoData include Everbeat, Eko Health, Gauss Surgical, now a part of Stryker, iMEDRIX INC., Elaitra. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

EnsoData and Everbeat are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

EnsoData

General Information

Track EnsoData

Discover More

About EnsoData

Funding Rounds & Investors (6)

EnsoData Alternatives & Competitors

FAQ About EnsoData

Don't just browse. Track.